Overview of Tibsovo Instructions for Use

Ivonib (trade name: Tibsovo), as a highly effective oral targeted therapy for isocitrate dehydrogenase-1 (IDH1) mutant cancer, has brought new treatment hope to patients with specific cancers. The following is a concise guide to the use of ivosidenib, designed to help patients better understand and use this drug.

1. Applicable objects

Avosidenib is mainly suitable for adult cancer patients carrying IDH1 mutations, including relapsed or refractory acute myeloid leukemia (AML), newly diagnosed AML (in combination with azacitidine under certain conditions), relapsed or refractory myelodysplastic syndrome (MDS), and patients with previously treated locally advanced or metastatic cholangiocarcinoma.

2. Medication guidance

1. Recommended dosage: Adult patients take orally once a day, 500mg each time. The tablets can be taken with food or on an empty stomach, but avoid taking them with fatty foods.

2. Medication time: It is recommended to take the medication at the same time every day to ensure the stability of the drug concentration.

3. Tablet handling: Tablets should be swallowed whole and should not be broken, crushed or chewed.

3. Precautions

1. Take medication as directed by the doctor: Patients should strictly follow the doctor's prescription and medication instructions, and are not allowed to adjust the dosage or stop medication on their own.

2. Side effect monitoring: During the use of ivonib, patients may experience side effects such as nausea, vomiting, diarrhea, fatigue, etc. Patients should pay close attention to their symptoms and promptly report any discomfort to their doctor.

3. Regular follow-up: During the treatment period, patients should receive regular medical monitoring and examinations so that doctors can evaluate the treatment effect and adjust the treatment plan in a timely manner.

4. Avoid drug interactions: Please inform your doctor of all medications you are taking, including prescription drugs, over-the-counter drugs, and supplements, to prevent potential drug interactions.

5. Medication for special groups: Elderly patients, patients with liver and kidney dysfunction, and pregnant and lactating women should use ivonib with caution under the guidance of a doctor.

4. Storage and disposal

Avonib should be stored in a dry, cool place at room temperature, away from direct sunlight and high temperature environments. Unused medicines should be disposed of in accordance with local regulations and should not be thrown away.

In conclusion, ivosidenib provides a new treatment option for cancer patients carryingIDH1 mutations. Patients should strictly follow the doctor's instructions, use medications rationally, and pay close attention to changes in their symptoms to ensure the safety and effectiveness of treatment. Currently, patients can purchase the original drug of ivonib in domestic pharmacies, but the price is higher. In addition, Laos also provides generic versions of the drug at relatively affordable prices.